Winton Group’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.3M	Buy	367,883 +178,577	+94%	+$1.42M	0.12%	242
2025 Q4	$1.14M	Buy	189,306 +131,555	+228%	+$783K	0.04%	436
2025 Q3	$330K	Buy	+57,751	New	+$295K	0.01%	618
2025 Q2	–	Sell	-35,384	Closed	-$229K	–	1015
2025 Q1	$229K	Sell	35,384 -56,851	-62%	-$505K	0.01%	608
2024 Q4	$677K	Sell	92,235 -38,730	-30%	-$305K	0.05%	420
2024 Q3	$981K	Buy	130,965 +31,254	+31%	+$271K	0.07%	330
2024 Q2	$887K	Buy	99,711 +18,668	+23%	+$179K	0.06%	341
2024 Q1	$821K	Buy	+81,043	New	+$825K	0.06%	371
2023 Q4	–	Sell	-14,943	Closed	-$140K	–	862
2023 Q3	$140K	Sell	14,943 -5,028	-25%	-$71.7K	0.01%	699
2023 Q2	$490K	Sell	19,971 -50,017	-71%	-$1.26M	0.04%	329
2023 Q1	$1.63M	Buy	69,988 +17,249	+33%	+$441K	0.1%	272
2022 Q4	$1.33M	Sell	52,739 -4,903	-9%	-$120K	0.09%	326
2022 Q3	$1.11M	Buy	57,642 +9,871	+21%	+$251K	0.07%	376
2022 Q2	$1.22M	Buy	47,771 +32,432	+211%	+$757K	0.06%	422
2022 Q1	$395K	Buy	15,339 +2,325	+18%	+$69K	0.02%	745
2021 Q4	$545K	Sell	13,014 -720	-5%	-$28.2K	0.03%	652
2021 Q3	$598K	Buy	13,734 +609	+5%	+$26.4K	0.03%	768
2021 Q2	$621K	Buy	13,125 +1,875	+17%	+$85.2K	0.03%	798
2021 Q1	$577K	Sell	11,250 -3,844	-25%	-$207K	0.03%	797
2020 Q4	$404K	Sell	15,094 -37,077	-71%	-$1.21M	0.03%	897
2020 Q3	$1.79M	Buy	+52,171	New	+$2.25M	0.06%	581